Literature DB >> 19660491

Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.

Andrew J Kwilasz1, Louis S Harris, Robert E Vann.   

Abstract

The introduction of transgenic and knockout mice has shaped new interest in developing novel and modified behavioral methods for mice that evaluate the various manifestations of nicotine withdrawal syndromes. This study assessed the disruption of operant baselines during drug withdrawal, an established rat model of nicotine dependence, in mice. Subjects were trained to lever press for food reinforcement during daily operant sessions. After stable operant baselines were established, mice were implanted with osmotic minipumps containing 0 (saline), 6, 12, 24, or 48 mg/kg/day nicotine base. Operant responding was assessed for disruptions in daily sessions throughout the experiment. Somatic signs of withdrawal were assessed after the operant session on day 7, following administration of mecamylamine (1 mg/kg), and on days 12, 13, and 14, following spontaneous removal of nicotine. Spontaneous removal of nicotine increased somatic signs of withdrawal but did not disrupt operant responding. Mecamylamine failed to produce signs of precipitated withdrawal in either procedure. This study demonstrated nicotine dependence in mice during spontaneous removal of nicotine. Moreover, since signs of behavioral withdrawal (i.e. disruptions in operant response rates) were not observed, these findings suggest the importance of considering differences in the apparent manifestations of withdrawal syndromes while evaluating nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660491      PMCID: PMC2755243          DOI: 10.1016/j.pbb.2009.07.015

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  34 in total

1.  Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats.

Authors:  Robert E Vann; Robert L Balster; Patrick M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  2005-07-07       Impact factor: 4.530

Review 2.  Bupropion for the treatment of nicotine withdrawal and craving.

Authors:  Marc E Mooney; Mehmet Sofuoglu
Journal:  Expert Rev Neurother       Date:  2006-07       Impact factor: 4.618

3.  Bupropion attenuates nicotine abstinence syndrome in the rat.

Authors:  David H Malin; J Ronald Lake; Tanya D Smith; Habil N Khambati; Rhonda L Meyers-Paal; Ana L Montellano; Ryan E Jennings; Daniel S Erwin; Stacey E Presley; Barbara A Perales
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

4.  Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit.

Authors:  Ramiro Salas; Fredalina Pieri; Mariella De Biasi
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.167

5.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

6.  Intravenous nicotine conditions a place preference in rats using an unbiased design.

Authors:  Jamie L Wilkinson; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-09-01       Impact factor: 3.533

7.  Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity.

Authors:  D R Helton; D L Modlin; J P Tizzano; K Rasmussen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Nicotine dependence and reward differ between adolescent and adult male mice.

Authors:  D Kota; B R Martin; S E Robinson; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2007-04-19       Impact factor: 4.030

9.  Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.

Authors:  K J Jackson; B R Martin; J P Changeux; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-01-09       Impact factor: 4.030

10.  Nicotine place preference in a biased conditioned place preference design.

Authors:  Jennifer M Brielmaier; Craig G McDonald; Robert F Smith
Journal:  Pharmacol Biochem Behav       Date:  2007-11-22       Impact factor: 3.533

View more
  1 in total

1.  Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence.

Authors:  Zheng-Xiong Xi; Pretal Muldoon; Xiao-Fei Wang; Guo-Hua Bi; M Imad Damaj; Aron H Lichtman; Roger G Pertwee; Eliot L Gardner
Journal:  Br J Pharmacol       Date:  2019-10-28       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.